Enalapril liquid - Silvergate Pharmaceuticals

Drug Profile

Enalapril liquid - Silvergate Pharmaceuticals

Alternative Names: Enalapril maleate - Silvergate Pharmaceuticals; Epaned; Epaned Kit

Latest Information Update: 22 Sep 2016

Price : $50

At a glance

  • Originator Silvergate Pharmaceuticals
  • Class Antihypertensives; Heart failure therapies; Small molecules
  • Mechanism of Action ACE inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Heart failure; Hypertension; Left ventricular dysfunction

Most Recent Events

  • 20 Sep 2016 Registered for Heart failure in USA (PO)
  • 20 Sep 2016 Registered for Hypertension in USA (PO)
  • 20 Sep 2016 Registered for Left ventricular dysfunction in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top